MX353426B - Composicion de recubrimiento apropiada para formas de dosificacion farmaceuticas o nutraceuticas. - Google Patents

Composicion de recubrimiento apropiada para formas de dosificacion farmaceuticas o nutraceuticas.

Info

Publication number
MX353426B
MX353426B MX2013014143A MX2013014143A MX353426B MX 353426 B MX353426 B MX 353426B MX 2013014143 A MX2013014143 A MX 2013014143A MX 2013014143 A MX2013014143 A MX 2013014143A MX 353426 B MX353426 B MX 353426B
Authority
MX
Mexico
Prior art keywords
pharmaceutical
core
coating composition
composition suitable
dosage forms
Prior art date
Application number
MX2013014143A
Other languages
English (en)
Other versions
MX2013014143A (es
Inventor
Meier Christian
Hendrik Schattka Jan
Hermes Florian
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of MX2013014143A publication Critical patent/MX2013014143A/es
Publication of MX353426B publication Critical patent/MX353426B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/12—Polymerisation in non-solvents
    • C08F2/16—Aqueous medium
    • C08F2/22—Emulsion polymerisation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/12—Esters of monohydric alcohols or phenols
    • C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F265/00—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00
    • C08F265/04—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00 on to polymers of esters
    • C08F265/06—Polymerisation of acrylate or methacrylate esters on to polymers thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2207/00—Properties characterising the ingredient of the composition
    • C08L2207/53—Core-shell polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con una composición de recubrimiento apropiada para el recubrimiento de una forma de dosificación farmacéutica o nutracéutica, que comprende un centro que contiene uno o más ingredientes activos farmacéuticos o nutracéuticos, en donde la composición de recubrimiento comprende por lo menos 20% en peso de una composición polimérica entérica de centro/capa derivada de un proceso de polimerización en emulsión, en donde el centro de la composición polimérica de centro/capa se forma por un polímero o copolímero reticulado, insoluble en agua y la capa de la composición polimérica de centro/capa se forma por un polímero o copolímero aniónico.
MX2013014143A 2011-06-17 2011-06-17 Composicion de recubrimiento apropiada para formas de dosificacion farmaceuticas o nutraceuticas. MX353426B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/060097 WO2012171576A1 (en) 2011-06-17 2011-06-17 Coating composition suitable for pharmaceutical or nutraceutical dosage forms

Publications (2)

Publication Number Publication Date
MX2013014143A MX2013014143A (es) 2014-01-23
MX353426B true MX353426B (es) 2018-01-12

Family

ID=44627081

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014143A MX353426B (es) 2011-06-17 2011-06-17 Composicion de recubrimiento apropiada para formas de dosificacion farmaceuticas o nutraceuticas.

Country Status (16)

Country Link
US (1) US9668977B2 (es)
EP (1) EP2720681B1 (es)
JP (1) JP5832645B2 (es)
KR (1) KR101799625B1 (es)
CN (1) CN103501767A (es)
AU (1) AU2011370763A1 (es)
BR (1) BR112013028453B8 (es)
CA (1) CA2839494C (es)
ES (1) ES2617402T3 (es)
HU (1) HUE033117T2 (es)
IL (1) IL228397A (es)
MX (1) MX353426B (es)
PL (1) PL2720681T3 (es)
RU (1) RU2599023C2 (es)
SI (1) SI2720681T1 (es)
WO (1) WO2012171576A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9775815B2 (en) * 2011-06-17 2017-10-03 Evonik Roehm Gmbh Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
CN105943519A (zh) * 2016-06-22 2016-09-21 福建省微生物研究所 一种苯磺贝他斯汀掩味颗粒
KR102408027B1 (ko) * 2016-08-15 2022-06-15 에보니크 오퍼레이션즈 게엠베하 증진된 탈유화성 성능을 갖는 관능성 폴리알킬 (메트)아크릴레이트
EP3709979A1 (en) 2017-11-17 2020-09-23 Evonik Operations GmbH Process for preparing a coated hard shell capsule
JP2021524840A (ja) 2018-05-24 2021-09-16 セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー 高分子薬剤化合物の持続放出用の埋め込み型デバイス
SG11202005947RA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
CN109232795A (zh) * 2018-09-21 2019-01-18 佛山市森昂生物科技有限公司 一种防水型高韧性包衣材料的制备方法
WO2020221522A1 (en) 2019-04-30 2020-11-05 Evonik Operations Gmbh Pellet and multi-unit pellet system (mups)
US20220241155A1 (en) * 2019-05-15 2022-08-04 Evonik Operations Gmbh Process for preparing filled hard-shell capsules with cellulose or starch-based coatings with a capsule-filling machine
IL308701A (en) 2021-05-25 2024-01-01 Evonik Operations Gmbh Hard shell capsules with modified release coating
IL308707A (en) 2021-05-25 2024-01-01 Evonik Operations Gmbh Capsule with a hard shell with prevention of the flow of gastric fluids
EP4176874A1 (en) 2021-11-09 2023-05-10 Evonik Operations GmbH Pharmaceutical or nutraceutical composition with an alcohol resistant single layer coating system
WO2023174722A1 (en) 2022-03-15 2023-09-21 Evonik Operations Gmbh Pre-functionalized hard shell capsule with accelerated drug release at ph value 5 to 5.5
WO2023214016A1 (en) 2022-05-06 2023-11-09 Evonik Operations Gmbh Dosage form with drug release at ph 3 to 6 using double coating system with at least one release acceleration agent

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2135073C3 (de) 1971-07-14 1974-07-11 Roehm Gmbh Überzugsmittel für Arzneiformen
US4876313A (en) * 1986-08-29 1989-10-24 Rohm And Haas Company Grafted core-shell polymer compositions using polyfunctional compounds
DE9414065U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE9414066U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE19615812A1 (de) 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
AU771383B2 (en) * 1998-12-08 2004-03-18 Rohm And Haas Company Dirt pickup resistant coating binder and coatings
AUPQ164299A0 (en) 1999-07-14 1999-08-05 Orica Australia Pty Ltd Aqueous polymer dispersion
DE10208335A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
MXPA04010956A (es) 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
AU2003903838A0 (en) 2003-07-23 2003-08-07 Orica Australia Pty Ltd Aqueous polymer dispersion
TWI350762B (en) * 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
EP1754766B1 (en) * 2004-05-07 2011-08-17 Asahi Kasei Chemicals Corporation Aqueous resin dispersion for adhesive and composition thereof
DE102004036437A1 (de) * 2004-07-27 2006-03-23 Röhm GmbH & Co. KG Multipartikuläre Arzneiform für wenig lösliche Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
EP1811975A2 (en) * 2004-10-19 2007-08-01 The State of Oregon Acting by and Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
WO2006132471A1 (en) 2005-06-07 2006-12-14 Lg Chem, Ltd. Polymeric lubricant having multi layer structure and manufacturing method thereof
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
US20080058473A1 (en) 2006-08-31 2008-03-06 Yakov Freidzon Latex for low VOC paint having improved block resistance, open time and water-softening resistance
DE102006051020A1 (de) 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
KR101454056B1 (ko) 2007-09-21 2014-10-27 에보니크 룀 게엠베하 에탄올의 영향에 대하여 내성을 가지는 비-오피오이드용 ｐｈ-의존성 조절 방출 제약 조성물
CN101801357B (zh) 2007-09-21 2013-08-07 赢创罗姆有限公司 耐受乙醇的影响的pH依赖性受控释放的药物组合物
CN102164589A (zh) 2008-09-24 2011-08-24 赢创罗姆有限公司 耐受乙醇影响的非阿片类药物的pH依赖性受控释放的药物组合物
SI2341899T1 (sl) 2008-09-24 2015-04-30 Evonik Roehm Gmbh Od pH odvisen opioidni farmacevtski sestavek z nadzorovanim sproščanjem z odpornostjo na vpliv etanola
HUE032817T2 (en) 2009-03-18 2017-11-28 Evonik Roehm Gmbh Regulated release pharmaceutical composition comprising a coating containing neutral vinyl polymers and excipients and resistant to the influence of ethanol
BRPI0924427A2 (pt) 2009-03-18 2016-01-26 Evonik Roehm Gmbh composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma
CA2804929A1 (en) * 2010-07-09 2012-01-12 Lubrizol Advanced Materials, Inc. Structured acrylate copolymer thickeners

Also Published As

Publication number Publication date
JP2014517018A (ja) 2014-07-17
RU2014101228A (ru) 2015-07-27
ES2617402T3 (es) 2017-06-19
KR101799625B1 (ko) 2017-11-20
JP5832645B2 (ja) 2015-12-16
CA2839494C (en) 2018-11-06
PL2720681T3 (pl) 2017-05-31
HUE033117T2 (en) 2017-11-28
SI2720681T1 (sl) 2017-03-31
US20140079792A1 (en) 2014-03-20
BR112013028453B8 (pt) 2022-07-05
KR20140041545A (ko) 2014-04-04
IL228397A (en) 2017-07-31
EP2720681A1 (en) 2014-04-23
RU2599023C2 (ru) 2016-10-10
US9668977B2 (en) 2017-06-06
IL228397A0 (en) 2013-12-31
AU2011370763A1 (en) 2013-10-03
EP2720681B1 (en) 2016-11-23
CN103501767A (zh) 2014-01-08
BR112013028453A2 (pt) 2017-01-24
CA2839494A1 (en) 2012-12-20
MX2013014143A (es) 2014-01-23
WO2012171576A1 (en) 2012-12-20
BR112013028453B1 (pt) 2021-10-19

Similar Documents

Publication Publication Date Title
MX353426B (es) Composicion de recubrimiento apropiada para formas de dosificacion farmaceuticas o nutraceuticas.
MX353427B (es) Composicion de recubrimiento adecuada para formas de dosis farmaceuticas o nutraceuticas.
MX355662B (es) Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influencia de etanol.
GEP20166457B (en) Low-oil pharmaceutical emulsion compositions comprising progestogen
MX356111B (es) Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
WO2016137235A3 (ko) 마이크로 rna를 유효 성분으로 포함하는 암 치료용 약학 조성물
MX347227B (es) Composicion farmaceutica o nutraceutica con liberacion sostenida caracteristica y con resistencia contra la influencia del etanol.
PH12015500106B1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
PH12017502326B1 (en) Orodispersible dosage unit containing an estetrol component
MX2015000917A (es) Composiciones de productos de consumo que comprenden emulsiones de organopolisiloxano.
BR112012026596A2 (pt) método para preparar composições farmacêuticas pretendidas para administração oral compreendendo um ou mais ingredientes ativos e as composições que compreendem as mesmas
MX2017015465A (es) Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol.
TN2013000239A1 (en) New form of administration of enkephalinase inhibitor
EA033448B1 (ru) Композиция орлистата и акарбозы с модифицированным высвобождением для лечения ожирения и связанных метаболических нарушений
WO2017136617A8 (en) Deuterated domperidone compositions and methods for therapy of disorders
WO2016190682A3 (ko) 모루신, 구와논 지 또는 상백피를 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물
WO2012162439A3 (en) Compositions comprising fusidic acid and packages therefor
MX2017009358A (es) Proceso para la preparacion de microcapsulas libres de melamina-formaldehido.
MD4563B1 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
BR112015009453A2 (pt) composição farmacêutica estável de peg-interferona alfa-2b
BR112017014016A2 (pt) método de redução da pressão intraocular, e, composição farmacêutica.
PH12014502836A1 (en) Medicament form for release of active ingredients
ZA201905664B (en) Novel dosage form
UA108277C2 (ru) Комплексный препарат, содержащий лерканидипина гидрохлорид и валсартан, и способ его получения
WO2013091970A3 (de) Mittel zur temporären verformung keratinischer fasern auf grundlage einer kombination spezifischer filmbildender polymere

Legal Events

Date Code Title Description
FG Grant or registration